AzTrials
AzTrials

Suicide PreventionCSNLNCT06364332

Chatsafe Netherlands: Improving Safe Suicide Communication for Young People on Social Media

A study testing Social Media campaign in people with Suicide Prevention and Communication, run by 113 Suicide Prevention at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Suicide is the leading cause of death among young people (YP) aged 10 to 25 years in the Netherlands. In addition, YP report high rates of suicidal ideation (16%). While suicidal behavior is a complex phenomenon with many factors and causes, the role of social media is becoming more prominent, especially for YP. Read more about this study

Who is it for?
Ages 16 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Suicide Prevention, Communication, Social Media
What is being tested?
Social Media campaign
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteNetherlands
Study dates
8 Apr 2024to Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • age between 16-25 years,
  • living in the Netherlands and speaking Dutch,
  • see themselves as active social media user,
  • is willing to share mobile phone number with the research team.

Who cannot join

  • None, if participants meet the inclusion criteria, they can principally participate in the study; having suicidal ideation is not a reason for exclusion. An extensive safety procedure is drawn up, which describes how the safety of the participants is monitored.

Trial locations and contacts

1 site in 1 country.

Elke Elzinga, dr contact

020 3113883

e.elzinga@113.nl

Saskia Mérelle, dr contact

020 3113883

s.merelle@113.nl

Netherlands1 site, 1 recruiting
  • 113 Suicide Prevention

    Amsterdam, North Holland, 1105 BP

    Elke Elzinga, dr, 020 3113883, e.elzinga@113.nl

    Saskia Mérelle, dr, 020 3113883, s.merelle@113.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Testing the Impact of #ChatsafeNL in a Randomized Controlled Trial: Does a Social Media Intervention Improve Dutch Young People's Safe Online Communication About Suicide?

Suicide is the leading cause of death among young people (YP) aged 10 to 25 years in the Netherlands. In addition, YP report high rates of suicidal ideation (16%). While suicidal behavior is a complex phenomenon with many factors and causes, the role of social media is becoming more prominent, especially for YP. Social media has been shown to be a source where YP can find support, but it's also a place where suicidal behavior is glorified or normalized, which can be triggering or harmful to other social media consumers.

The #Chatsafe guidelines were developed by Orygen Australia to better equip young people to communicate safely about suicide on social media. These guidelines are supported by a social media campaign to make the content of the guidelines more accessible to them. The #Chatsafe intervention consists of both the guidelines and the social media campaign. A small-scale Australian feasibility study showed promising results in terms of the acceptance and safety of the campaign, and safety regarding communicating about suicide on social media platforms. Currently, in Australia it is tested to what extent these results hold up in a Randomized Controlled Trial (RCT) (Robinson et al., 2023).

With funding from the Dutch National Agenda for Suicide Prevention, a contextualized replication study is conducted. The aim of this study is to determine whether the #Chatsafe intervention has an effect on the way in which Dutch YP communicate online about suicide.

Read the detailed description

The #Chatsafe guidelines were developed by Orygen to better equip YP to communicate safely about suicide on social media. These guidelines are supported by a national social media campaign to make the content of the guidelines more accessible to the target group. The #Chatsafe intervention consists of both the guidelines and a social media campaign. A small-scale Australian feasibility study showed promising results in terms of acceptance and safety of the campaign, as well as the willingness of young people to intervene against suicide, their perceived self-efficacy, confidence, and safety regarding communicating about suicide on social media platforms. To test whether the effects hold up in a controlled setting, a Randomized Controlled Trial (RCT) is conducted.

With funding from the Dutch National Agenda for Suicide Prevention, commissioned by 113 Suicide Prevention, the #Chatsafe campaign is being translated to fit the Dutch context through a co-design process involving end users. To investigate whether this campaign has the intended effect in the Netherlands, a contextualized replication study into the efficacy of ChatsafeNL (Chatsafe Netherlands) is conducted in a controlled setting. The aim of the research is to determine whether the #ChatsafeNL intervention affects how YP, both with and without suicidal ideation, communicate online about suicide. A group receiving #ChatsafeNL content (intervention group) will be compared with a group who received content about sexual health and wellbeing (control group).

In the current study, the efficacy of the #ChatsafeNL intervention is tested in an RCT. The intervention condition (#ChatsafeNL social media intervention) is compared with a control intervention (sexual health campaign). The intervention phase lasts 8 weeks. Participants will be recruited over a period of 6-12 months.

Participants are asked to complete a self-report questionnaire at three different times, namely prior to the intervention (baseline, T1), immediately after the 8-week intervention (T2) and 4 weeks post-intervention (T3). During the intervention period, participants receive campaign content every week for 8 weeks. They are offered a short questionnaire to monitor safety and assess the evaluation of the content.

Initially, the campaign is developed for Instagram. This may expand to other social media platforms later on.

Being tested
Social Media campaign
Keywords
Suicide prevention, Suicidal Ideation, Communication, Social Media
Medical subject headings
Suicide Prevention, Communication, Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social Media campaignBehavioural

    Participants receive content three times a week; in total 24 pieces of content in 8 weeks. The content can consist of one or more photos or images with a caption (explanation in text).

Study groups in NCT06364332
Study groupRoleWhat they receive
InterventionExperimental#Chatsafe suicide prevention content.
Receives: Behavioral: Social Media campaign
ControlActive comparatorSexual health and wellbeing content
Receives: Behavioral: Social Media campaign

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Safe communication about suicide online

    This outcome measure was specially developed for the Chatsafe Australia study, it will be measured by the purpose-designed #Chatsafe online safety questionnaire (Robinson et al., 2023) immediately after intervention. It is based upon an adapted version of the Perceived Safety Questionnaire.

    It consists of 4 different subscales, for each of which a sum score will be calculated: general use, seeing content, responding to content and interacting with content on social media. Overall sum score on communicating about self-harm and suicide on social media (25 items) ranges from 25-100, where higher scores reflect more safe communication.

    In addition, vignettes will be used to calculate scores concerning: sharing experiences of suicide online score, responding online to someone at risk and communication online about a suicide that has occurred (range 53-265). Here, also higher scores reflect more safe communication.

    Measured: Before, immediately after intervention and at 4 week follow up

Secondary outcomes (6)
  1. Confidence when communicating about suicide online

    measured by the #Chatsafe online safety questionnaire

    Measured: Before, immediately after intervention and at 4 week follow up

  2. Willingness to intervene against suicide online

    measured via the Willingness to Intervene Questionnaire

    Measured: Before, immediately after intervention and at 4 week follow up

  3. Self-efficacy online

    measured by the Internet Self-Efficacy Questionnaire

    Measured: Before, immediately after intervention and at 4 week follow up

  4. Safety of the #ChatsafeNL materials

    measured by the weekly evaluation survey

    Measured: Before, immediately after intervention and at 4 week follow up

  5. Acceptability of the #ChatsafeNL intervention

    measured by the evaluation questions

    Measured: Before, immediately after intervention and at 4 week follow up

  6. Safety of the #ChatsafeNL intervention

    This is measured, among other things, by the number (or absence of) adverse events during the study period, such as a response to item 9 of the Patient Health Questionnaire that indicates they experience suicidal ideation, a response to the weekly questionnaire indicating that participants find the content disturbing, responses to the questionnaire that indicates that certain campaign content distressed participants and whether the research team was contacted by respondents to report distress or risk of self-harm or suicide.

    Measured: Before, immediately after intervention and at 4 week follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2024
  2. Study start8 Apr 2024
  3. Primary completionDec 2024 (estimated)
  4. Study completionMar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomized to the intervention or the control group using block randomization with varying block sizes (block sizes vary from 2 to 16). The distribution key will be 1:1. The randomization schedule is computer generated by a researcher who will not be part of the analysing researchers.
Masking
Single blind
Who is masked
Investigator
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06364332
Sponsor's protocol ID
ChatsafeNL
Other IDs
2023.0348
Acronym
CSNL
Status last verified
Apr 2024
First submitted
2 Apr 2024
Last updated
1 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data will be made available upon reasonable request

Publications

  • Robinson J, La Sala L, Cooper C, Spittal M, Rice S, Lamblin M, Brown E, Nolan H, Battersby-Coulter R, Rajaram G, Thorn P, Pirkis J, May-Finlay S, Silenzio V, Skehan J, Krysinska K, Bellairs-Walsh I. Testing the Impact of the #chatsafe Intervention on Young People's Ability to Communicate Safely About Suicide on Social Media: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Feb 17;12:e44300. doi: 10.2196/44300.

    PubMed 36800220
  • La Sala L, Pirkis J, Cooper C, Hill NTM, Lamblin M, Rajaram G, Rice S, Teh Z, Thorn P, Zahan R, Robinson J. Acceptability and Potential Impact of the #chatsafe Suicide Postvention Response Among Young People Who Have Been Exposed to Suicide: Pilot Study. JMIR Hum Factors. 2023 May 19;10:e44535. doi: 10.2196/44535.

    PubMed 37204854
  • La Sala L, Teh Z, Lamblin M, Rajaram G, Rice S, Hill NTM, Thorn P, Krysinska K, Robinson J. Can a social media intervention improve online communication about suicide? A feasibility study examining the acceptability and potential impact of the #chatsafe campaign. PLoS One. 2021 Jun 15;16(6):e0253278. doi: 10.1371/journal.pone.0253278. eCollection 2021.

    PubMed 34129610

Questions about this trial

What is this clinical trial studying?

A study testing Social Media campaign in people with Suicide Prevention and Communication, run by 113 Suicide Prevention at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Elke Elzinga, dr (020 3113883, e.elzinga@113.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Safe communication about suicide online (time frame: Before, immediately after intervention and at 4 week follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06364332, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in